Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Debt / NOTE 2.500% 2/1
-
Number of holders
-
9
-
Total 13F principal, excl. options
-
21,164,000
-
Principal change
-
-4,000
-
Total reported value, excl. options
-
$20,840,000
-
Value change
-
+$27,695
-
Number of buys
-
1
-
Number of sells
-
2
-
Price
-
$1.00
Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q4 2018
As of 31 Dec 2018 AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 had 9 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $21,164,000 principal (par value or face value) of the bond of the company.
Largest 9 bondholders included Birch Grove Capital LP, TENOR CAPITAL MANAGEMENT Co., L.P., Bruce & Co., Inc., JPMORGAN CHASE & CO, SONORA INVESTMENT MANAGEMENT, LLC, ROYAL BANK OF CANADA, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, and North Star Investment Management Corp..
This table shows 9 bond principal holders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.